So powerful to hear Dr. Nanette Wenger share the history of women’s 💙 care and discuss the future at @emorywomenheart 20th anniversary meeting! What a 💙 hero!!
Great talk on #Takotsubu syndrome at @emorywomenheart by @PujaKMehtaMD1
✨90% women
✨2/3 physical or emotional trigger
✨Not benign! Mortality ~ STEMI
✨MACE events common long-term
✨Strong association with Amygdala activity
Jonathan Kim @emorywomenheart discussing #SportsCardiology in women
✨#SCD Men 4x⬆️ than women
✨>35 yo: #CAD most common cause of #SCD
✨Women athletes have ⬆️ TWI, QT prolongation but ⬇️ Afib, CAC
🔥Reminder: EKG screening should NOT be mandatory but Emergency plan for #SCD/cardiac emergency should!
Peripheral Venous dz is such an important topic—especially in women! @emorywomenheart with Dr. Khushrow Niazi
✨#PVD: ⬆️2X >CAD, ⬆️5X >PAD
✨Affects 70% women >60 yo
✨Most common cause of leg ulcers
🔥 Ultrasound is test to diagnose BUT needs to be STANDING or can miss >50%
✨Tx: ⬇️prolonged standing/sitting, weight loss, walking, compression hose to thigh all first line
Update on Polyendocrine Metabolic Ovary Syndrome (#PMOS not PCOS now) at @emorywomenheart with Dr. Kalinda Woods.
✨Name changed from PCOS to recognize this is an ENDOCRINE d/o with high insulin
✨Increases #CVD risk
✨Lifestyle therapy with weight loss helps
✨Collaboration with OB/Gyn key
Fabulous update on Menopausal Hormone Therapy and #CVD risk at @emorywomenheart by @gina_lundberg
✨MHT decision is patient-centered!
✨Symptoms of menopause can be significant and multisystem
✨Trial data is complex in this area but ⬇️mortality seen overall
✨MHT has no role in prevention but excellent for SYMPTOMS
✨ALL perimenopausal women should have a CV risk assessment!
Thank you for your outstanding talk on Cardiac Rehab benefits in women!! So important to refer to CR after all ACS as well as HF, CABG and valve replacement as well as SCAD and Takotsubo!! #cvPrev
Familial hyperlipidemia is common and underdiagnosed! @ijeomaheartdoc updates us @emorywomenheart
✨Diagnosis is clinical: Genetic testing + only 60% of time
✨Genetic testing can be helpful but is NOT REQUIRED for dx
✨Earlier dx =Earlier Tx=⬇️CVD
✨Lots of tx options!!!
Still time to register for the 20th Annual Conference on Heart Disease in Women! Great speakers-Dr Wenger @a_l_bailey@gina_lundberg Dr Jonathan Kim @ijeomaheartdoc
Aug 22, 2026
Still time to register for the 20th Annual Conference on Heart Disease in Women! Great speakers-Dr Wenger @a_l_bailey@gina_lundberg Dr Jonathan Kim @ijeomaheartdoc
Aug 22, 2026
The 2026 Multisociety Guideline on #cvLipids supports #ASCVD-prevention strategies in childhood. This analysis highlights the role of early detection through exploration of FH, obesity-related dyslipidemia in children, & more. 🔗 https://t.co/UTFd8TkRXK #ACCPrev#cvPrev
Huge congratulations to Dr. Puja Mehta who has been appointed as the inaugural Stephen D. Clements, Jr, Professorship in Cardiology, endowed professorship (aka chair)!! So well deserved @PujaKMehtaMD1 !! The entire @emorywomenheart@emory_heart@EmoryDeptofMed are thrilled!